Molecular Biology of the Cell Sign up for new MBC in Press e-TOCs!

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Originally published as MBC in Press, 10.1091/mbc.E03-11-0825 on June 4, 2004 Originally published as MBC in Press, 10.1091/mbc.E03-11-0825 on May 28, 2004

Vol. 15, Issue 8, 3673-3687, August 2004

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
E03-11-0825v1
E03-11-0825v2
15/8/3673    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Estall, J. L.
Right arrow Articles by Drucker, D. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Estall, J. L.
Right arrow Articles by Drucker, D. J.

Lipid Raft-dependent Glucagon-like Peptide-2 Receptor Trafficking Occurs Independently of Agonist-induced Desensitization

Jennifer L. Estall, Bernardo Yusta, and Daniel J. Drucker *

Departments of Laboratory Medicine and Pathobiology, and Medicine, University of Toronto, The Banting and Best Diabetes Centre, Toronto General Hospital, Toronto, Canada M5G 2C4

Submitted November 18, 2003; Revised May 11, 2004; Accepted May 18, 2004
Monitoring Editor: Jennifer Lippincott-Schwartz

The intestinotrophic and cytoprotective actions of glucagon-like peptide-2 (GLP-2) are mediated by the GLP-2 receptor (GLP-2R), a member of the class II glucagon-secretin G protein-coupled receptor superfamily. Although native GLP-2 exhibits a short circulating half-life, long-acting degradation-resistant GLP-2 analogues are being evaluated for therapeutic use in human subjects. Accordingly, we examined the mechanisms regulating signaling, internalization, and trafficking of the GLP-2R to identify determinants of receptor activation and desensitization. Heterologous cells expressing the transfected rat or human GLP-2R exhibited a rapid, dose-dependent, and prolonged desensitization of the GLP-2–stimulated cAMP response and a sustained GLP-2–induced decrease in levels of cell surface receptor. Surprisingly, inhibitors of clathrin-dependent endocytosis failed to significantly decrease GLP-2R internalization, whereas cholesterol sequestration inhibited ligand-induced receptor internalization and potentiated homologous desensitization. The hGLP-2R localized to both Triton X-100–soluble and –insoluble (lipid raft) cellular fractions and colocalized transiently with the lipid raft marker caveolin-1. Although GLP-2R endocytosis was dependent on lipid raft integrity, the receptor transiently associated with green fluorescent protein tagged-early endosome antigen 1–positive vesicles and inhibitors of endosomal acidification attenuated the reappearance of the GLP-2R on the cell surface. Our data demonstrate that GLP-2R desensitization and raft-dependent trafficking represent distinct and independent cellular mechanisms and provide new evidence implicating the importance of a clathrin- and dynamin-independent, lipid raft-dependent pathway for homologous G protein-coupled receptor internalization.


Article published online ahead of print. Mol. Biol. Cell 10.1091/mbc.E03-11-0825. Article and publication date are available at www.molbiolcell.org/cgi/doi/10.1091/mbc.E03-11-0825.

* Corresponding author. E-mail address: d.drucker{at}utoronto.ca.




This article has been cited by other articles:


Home page
Mol. Biol. CellHome page
S. Langlois, K. N. Cowan, Q. Shao, B. J. Cowan, and D. W. Laird
Caveolin-1 and -2 Interact with Connexin43 and Regulate Gap Junctional Intercellular Communication in Keratinocytes
Mol. Biol. Cell, March 1, 2008; 19(3): 912 - 928.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
P. E. Dube and P. L. Brubaker
Frontiers in glucagon-like peptide-2: multiple actions, multiple mediators
Am J Physiol Endocrinol Metab, August 1, 2007; 293(2): E460 - E465.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
D. W. Nelson, J. W. Sharp, M. S. Brownfield, H. E. Raybould, and D. M. Ney
Localization and Activation of Glucagon-Like Peptide-2 Receptors on Vagal Afferents in the Rat
Endocrinology, May 1, 2007; 148(5): 1954 - 1962.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
C. A. Syme, L. Zhang, and A. Bisello
Caveolin-1 Regulates Cellular Trafficking and Function of the Glucagon-Like Peptide 1 Receptor
Mol. Endocrinol., December 1, 2006; 20(12): 3400 - 3411.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
Y. Ueda, N. F. Neel, E. Schutyser, D. Raman, and A. Richmond
Deletion of the COOH-Terminal Domain of CXC Chemokine Receptor 4 Leads to the Down-regulation of Cell-to-Cell Contact, Enhanced Motility and Proliferation in Breast Carcinoma Cells
Cancer Res., June 1, 2006; 66(11): 5665 - 5675.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. L. Estall, J. A. Koehler, B. Yusta, and D. J. Drucker
The Glucagon-like Peptide-2 Receptor C Terminus Modulates {beta}-Arrestin-2 Association but Is Dispensable for Ligand-induced Desensitization, Endocytosis, and G-protein-dependent Effector Activation
J. Biol. Chem., June 10, 2005; 280(23): 22124 - 22134.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Copyright © 2004 by The American Society for Cell Biology. Terms of copyright protection, warranties, and disclaimers.